XERS Market Cap & Key Metrics
Xeris Biopharma Holdings, Inc.
$10.07
+$0.30(+3.07%)
61
Overall
35
Value
75
Tech
73
Quality
Market Cap
$1.78B
Volume
1.94M
52W Range
$5.25 - $11.33
Target Price
$12.86
XERS market cap is $1.78B. This page lists Xeris Biopharma Holdings, Inc.'s P/E ratio, EPS estimates, dividend yield, payout ratio and MarketXLS scores.
XERS Key Metrics
- Market cap
- $1.78B
- P/E ratio (current-year EPS estimate)
- 143.86
- EPS estimate, current year
- $0.07
- EPS growth, 3-year
- +0.00%
- Value score
- 35
- Quality score
- 73
- Technical score
- 75
| Fiscal year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Revenue | $291.85M | $203.07M | $163.91M |
| EBITDA | $31.41M | -$10.99M | -$21.53M |
| EPS | - | $-0.37 | $-0.45 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | XERS | $10.07 | +3.1% | 1.94M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Xeris Biopharma Holdings, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW